|
TORONTO, ONTARIO--(Marketwired - June 11, 2014) - Merus Labs International Inc. ("the Company" or "Merus") (TSX:MSL)(NASDAQ:MSLI) is pleased to announce that it has entered into an agreement with a syndicate of investment dealers (the "Underwriters") pursuant to which the Underwriters have agreed to purchase 13,000,000 common shares ("Shares") from the treasury of the Company, at a price of $1.70 per Share for aggregate gross proceeds of $22,100,000 and offer them to the public by way of prospectus supplement (the "Offering"). |
